Forma Therapeutics Holdings Overview

Forma Therapeutics Holdings Research & Development

Research & Development expenses for FMTX.

Quarterly R&D Expenses

$39.06M

↑ 23.66% YoY

As of Jun 30, 2022

Annual R&D Expenses (TTM)

$138.06M

↑ 28.34% YoY

Trailing 12 months ending Jun 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin